European Survey of Cardiovascular Disease Prevention, Diabetes and Chronic Kidney Disease (EUROASPIRE VI)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Pr David A Wood, MB ChB MSc
National Institute for Prevention and Cardiovascular Health
Study Chair - Pr John William McEvoy, MB BCh BAO MEd MHS PhD
National Institute for Prevention and Cardiovascular Health
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Istanbul University, Cerrahpaşa Cardiology Institute
Istanbul, Turkey (Türkiye)
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Jun 2024
- Primary completion
- 31 Mar 2026
- Completion
- 31 Dec 2029
- Last update posted
- 20 Aug 2026
- Registered enrollment
- 8,000
- Registry id
- NCT06495177
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.